A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients

NCT00046332 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: GW810781

Sponsor

GlaxoSmithKline

Collaborators

[object Object]